Remedium Bio announces the publication of preclinical data demonstrating the performance of its adjustable dose gene therapy platform – Prometheus™
Posted:
Prometheus™ was specifically designed as a subcutaneously injected gene delivery system, utilizing the same route of administration as most current therapeutic biologics. Remedium is applying the Prometheus™ platform technology to the development of its lead candidate RMD1202, a single injection disease-modifying treatment for type 2 diabetes and obesity.
AI-powered care navigation can make a real difference in improving patient outcomes, but many health systems dealing with legacy infrastructure and data silos have yet to scale AI solutions.
Read more here.
b.well Connected Health, which offers a connected health data network, is partnering with AI-enabled conversational search engine Perplexity to allow Perplexity users to authorize access to their medical records and ask personalized health questions informed by their individual health history. …
Attendees
Sponsors and Exhibitors
Contact us